Issue Size. Sai Life Sciences IPO is a book-built issue of Rs 3,042.62 crores. The issue is a combination of a fresh issue of 1.73 crore shares aggregating

Sai Life Sciences Ltd.'s initial public offering entered the second day on Thursday. It was subscribed 0.89 times or 89% as of 11:06 a.m. The company aims to raise Rs 3,042 crore via the offering.

Sai Life Sciences IPO opened for for public subscription on Wednesday, December 11 and will close on Friday, December 13. The public issue has received healthy booking from the QIB segment on Day 1.

Sai Life Sciences IPO opens for public subscription today, Wednesday, December 11, 2024, and will close on Friday, December 13, 2024

Retail investors subscribed 8%, non-institutional investors 4%, while qualified institutional buyers made no bids yet for the Rs 3,042.62 crore IPO. The issue includes a fresh allotment of shares worth Rs 950 crore and an OFS of Rs 2,

Sai Life Sciences IPO GMP price, allotment, Subscription details: The company raised a sum of Rs 912.79 crore from anchor investors by selling 1.66 crore shares.

Shares of Sai Life Sciences were trading at a premium of ₹28 in the grey market, at 4:30 PM on December 11, as per reports. The latest GMP for Sai Life Sciences IPO indicates an expected listing price of ₹577 per share with a potential listing gain of 5%.

Sai Life Sciences is selling its shares in the price band of Rs 522-549 apiece, which could apply for a minimum of 27 shares and its multiples to raise a total of Rs 3,042.62 crore.

TPG Capital-backed Sai Life Sciences IPO opens at ₹522-549, with ₹3,043-crore valuation, offering fresh shares and stake sale.